Cargando…
Timeline and Potential Impact of CMS's Drug Competitive Acquisition Program (CAP)
Autor principal: | Rubinstein, Elan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437745/ http://dx.doi.org/10.18553/jmcp.2006.12.3.264 |
Ejemplares similares
-
Reevaluation of CMS’ Competitive Bidding Program
por: Schatz, Desmond, et al.
Publicado: (2016) -
How Much Spread in AWP Pricing Is Unlawful?
por: Rubinstein, Elan, et al.
Publicado: (2007) -
Grim Provider and Supplier Gross Margins of 1.8%-3.7% if CMS-1670-P Is Finalized As Proposed
por: Rubinstein, Elan
Publicado: (2016) -
Timeline: Vaccines
por: Rappuoli, Rino
Publicado: (2020) -
Online timeline
por: Carlson, David
Publicado: (2005)